| Trial ID: | L2131 |
| Source ID: | NCT00613782
|
| Associated Drug: |
Reandron 1000
|
| Title: |
Reandron in Diabetic Men Witn Low Testosterone Level
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Hypogonadism
|
| Interventions: |
DRUG: Reandron 1000|DRUG: placebo
|
| Outcome Measures: |
Primary: Insulin Resistance, 40 weeks | Secondary: Bone microarchitecture, 40 weeks
|
| Sponsor/Collaborators: |
Sponsor: Austin Health
|
| Gender: |
MALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2|PHASE3
|
| Enrollment: |
88
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-01
|
| Completion Date: |
2014-04
|
| Results First Posted: |
|
| Last Update Posted: |
2014-07-01
|
| Locations: |
Austin Health, Melbourne, Victoria, 3084, Australia
|
| URL: |
https://clinicaltrials.gov/show/NCT00613782
|
